Trial Profile
Prospective controlled clinical trial of metastatic breast cancer treatment with capecitabine/docetaxel in combination with beta epoetin as compared with sole capecitabine/docetaxel treatment
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2014
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary) ; Capecitabine; Docetaxel
- Indications Advanced breast cancer; Chemotherapy-induced anaemia
- Focus Therapeutic Use
- Sponsors Roche
- 31 May 2011 New trial record